Bone Marrow Transplantation

Top Story

Survival rates after HSCT have not improved among infants with malignant diseases

March 18, 2019
In the Journals

Allogeneic transplant fails to confer survival benefit for pediatric leukemia subtype

March 8, 2019
Allogeneic hematopoietic stem cell transplantation did not significantly improve survival compared with chemotherapy alone among children with newly diagnosed…
In the Journals

Expanded single cord blood unit decreases hematopoietic recovery time after transplantation

March 1, 2019
An ex vivo-expanded umbilical cord blood unit appeared safe and effective as a standalone hematopoietic stem cell graft, shortening time to neutrophil and platelet…
Meeting News

Rezafungin does not affect activity of agents commonly used in transplant patients

February 19, 2019
Rezafungin dosed concomitantly with other drugs in the treatment of invasive fungal infections in transplant patients resulted in no significant change in systematic…
More Headlines »

Advances in the Management of Toxicities Associated with Stem Cell Transplant

This activity is supported by an educational grant from Cumberland Pharmaceuticals.

Therapeutic options for the treatment of multiple myeloma continue to evolve. Currently, high-dose melphalan followed…
More »

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »